UnknownNot applicableNCT03470207

The Prospective Risk Factor Evaluation & Discovery In CTEPH Study

Studying Chronic thromboembolic pulmonary hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mark W. Dodson
Principal Investigator
Mark W Dodson, MD PhD
Intermountain Health Care, Inc.
Intervention
Post-pulmonary embolism follow up protocol(procedure)
Enrollment
130 enrolled
Eligibility
18 years · All sexes
Timeline
20182021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03470207 on ClinicalTrials.gov

Other trials for Chronic thromboembolic pulmonary hypertension

Additional recruiting or active studies for the same condition.

See all trials for Chronic thromboembolic pulmonary hypertension

← Back to all trials